MorbidityNCT07412301
The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study
An observational study of Morbidity and Celiac Axis Stenosis, run by Larissa University Hospital at 1 site in Greece.
Trial summary
The association between celiac axis stenosis and morbidity after pancreaticoduodenectomy is the primary focus of the study. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Morbidity, Celiac Axis Stenosis, Pancreaticoduodenectomy
- How many people
- 99 participants
- Where
- 1 siteGreece
- Study dates
- 14 Nov 2024to 14 Nov 2029
- How long will I take part?
- 1 Month
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Pancreatic cancer patients submitted to pancreaticojejunostomy in the University Hospital of Larissa
Who may be able to join
- Patients over 18 years old
- Diagnosis of pancreatic cancer
- Pancreaticoduodenectomy
Who cannot join
- Previous pancreatectomy
- Non resectable tumors
- Serious comorbidities
- Patients lost to follow up
Trial locations and contacts
1 site in 1 country.
About this study
The association between celiac axis stenosis and morbidity after pancreaticoduodenectomy is the primary focus of the study.
- Medical subject headings
- Pancreatic Neoplasms
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Without celiac axis stenosis | With celiac axis stenosis |
What is being measured
The primary outcome is the main question the study is designed to answer.
Morbidity
Measured: one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Feb 2026
- Study start14 Nov 2024
- Primary completion14 Nov 2028 (estimated)
- Study completion14 Nov 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MorbidityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 99 participants (estimated)
- Target duration
- 1 Month
Sponsor and investigators
- Lead sponsor
- Larissa University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Zacharopoulos Georgios, Larissa University Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07412301
- Sponsor's protocol ID
- HPB-CAS-2025-01
- Status last verified
- Feb 2026
- First submitted
- 9 Feb 2026
- Last updated
- 17 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 17 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study
- ClinicalTrials.gov ID
- NCT07412301
- Acronym / sponsor ID
- HPB-CAS-2025-01
- Study type
- Observational
- Recruitment status
- Active, not recruiting
- Enrolment
- 99 participants (estimated)
- Lead sponsor
- Larissa University HospitalUniversity, hospital or other
- Study start
- 14 Nov 2024 (actual)
- Primary completion
- 14 Nov 2028 (estimated)
- Study completion
- 14 Nov 2029 (estimated)
- First posted
- 17 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The association between celiac axis stenosis and morbidity after pancreaticoduodenectomy is the primary focus of the study.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 1 Month
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Without celiac axis stenosis | – | –With celiac axis stenosis |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Pancreatic cancer patients submitted to pancreaticojejunostomy in the University Hospital of Larissa
Key inclusion criteria (3 listed)
- Patients over 18 years old
- Diagnosis of pancreatic cancer
- Pancreaticoduodenectomy
Key exclusion criteria (4 listed)
- Previous pancreatectomy
- Non resectable tumors
- Serious comorbidities
- Patients lost to follow up
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Morbidity
Time frame: one month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Feb 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Morbidity
Active, not recruiting
Implementation of a Disparities in Labor Outcomes Dashboard
Labor Induction, Cesarean Birth
Not yet recruiting
Prediction and Prevention of Postoperative Mortality and Morbidity
Dementia, Postoperative Delirium (POD)
Recruiting
Safety and Efficacy of NTP in Thyroid Surgery: Pilot Study on Morbidity Prevention and Adjuvant Oncological Control
Thyroid Diseases, Wound Healing
Active, not recruiting
The Maternal Health Multilevel Intervention for Racial Equity (MIRACLE) Project
Maternal Morbidity and Mortality, Health Disparities
Recruiting
Scaling up Maternal Health Equity Best Practices
Maternal Mortality Disparities, Maternal Morbidity Disparities
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Morbidity and Celiac Axis Stenosis, run by Larissa University Hospital at 1 site in Greece.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: under way, not looking for participants, as of the sponsor's last update on 17 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Greece. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Morbidity (time frame: one month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Feb 2026.